Molecular Detection of Minimal Residual Disease Provides the Most Powerful Independent Prognostic Factor Irrespective of Clonal Architecture in Nucleophosmin (NPM1) Mutant Acute Myeloid Leukemia
Ivey A., Hills RK., Simpson MA., Jovanovic JV., Gilkes AF., Patel Y., Bhudia N., Farah H., Mason J., Wall K., Akiki S., Solomon E., McCaughan F., Linch DC., Gale RE., Vyas P., Freeman SD., Russell N., Burnett AK., Grimwade D.